冰岛的空气污染和儿童喘 - 来自低污染地区的结果
Ane Johannessen1, Throstur Thorsteinsson2, Camilla Geels3
1Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Environment international
|March 4, 2026
概括
即使是低水平的空气污染,特别是细颗粒物 (PM2.5),也与冰岛儿童喘住院和药物使用的风险更高有关. 减少污染暴露对于儿童的呼吸系统健康至关重要.
科学领域:
- 环境健康 环境健康
- 儿科呼吸系统医学 儿科呼吸系统医学
- 流行病学 流行病学
背景情况:
- 之前没有任何研究检查空气污染对冰岛儿童喘的影响.
- 研究了冰岛儿童产前和早期空气污染暴露与喘结果之间的关联.
研究的目的:
- 探索在怀孕和幼儿时期暴露于空气污染和随后的喘住院和冰岛儿童药物使用之间的关系.
主要方法:
- 利用了来自冰岛59,355例单独出生 (2005-2018) 的数据.
- 在怀孕期间和生命的前三年中评估住宅空气污染暴露 (PM2.5,PM10,NO2).
- 采用了考克斯回归分析,调整了各种母亲,后代和家庭因素.
主要成果:
- 3.9%的儿童住院治疗喘;18.6%使用喘药物.
- 增加喘住院的风险与PM2.5 (HR 1.59),PM10和NO2等污染物有关,即使在低水平.
- 怀孕期间接触各种污染物,包括PM2.5,与使用喘药物的增加有关.
结论:
- 即使在低水平的空气污染暴露,也与冰岛儿童喘住院和药物使用的增加有关.
- 细颗粒物 (PM2.5) 成为一个重要的风险因素.
- 调查结果强调了持续努力以尽量减少空气污染暴露对儿童健康的影响的重要性.
相关概念视频
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications
3.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.5K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K


